Jukič, M.; Škrlj, B.; Tomšič, G.; Pleško, S.; Podlipnik, Č.; Bren, U.
Prioritisation of Compounds for 3CLpro Inhibitor Development on SARS-CoV-2 Variants. Molecules 2021, 26, 3003.
https://doi.org/10.3390/molecules26103003
AMA Style
Jukič M, Škrlj B, Tomšič G, Pleško S, Podlipnik Č, Bren U.
Prioritisation of Compounds for 3CLpro Inhibitor Development on SARS-CoV-2 Variants. Molecules. 2021; 26(10):3003.
https://doi.org/10.3390/molecules26103003
Chicago/Turabian Style
Jukič, Marko, Blaž Škrlj, Gašper Tomšič, Sebastian Pleško, Črtomir Podlipnik, and Urban Bren.
2021. "Prioritisation of Compounds for 3CLpro Inhibitor Development on SARS-CoV-2 Variants" Molecules 26, no. 10: 3003.
https://doi.org/10.3390/molecules26103003
APA Style
Jukič, M., Škrlj, B., Tomšič, G., Pleško, S., Podlipnik, Č., & Bren, U.
(2021). Prioritisation of Compounds for 3CLpro Inhibitor Development on SARS-CoV-2 Variants. Molecules, 26(10), 3003.
https://doi.org/10.3390/molecules26103003